These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2150525)

  • 1. [Ovarian stimulation for in vitro fertilization using LHRH agonists: comparison of plasma and intra-follicular hormone profiles using "short" and "long" protocols].
    Antoine JM; Firmin C; Alvarez S; Cornet D; Tibi C; Mandelbaum J; Plachot M; Salat-Baroux J
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(8):1035-40. PubMed ID: 2150525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of plasma and follicular fluid hormone profiles following stimulation with HMG, with or without LHRH agonists, for in-vitro fertilization.
    Firmin C; Antoine JM; Millot F; Alvarez S; Debray M; Tibi C; Cornet D; Salat-Baroux J; Laruelle P
    Hum Reprod; 1991 May; 6(5):653-8. PubMed ID: 1834692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of preovulatory elevations of plasma progesterone during in vitro fertilization using LHRH agonists in a long protocol].
    Antoine JM; Firmin C; Salat-Baroux J; Alvarez S; Cornet D; Mandelbaum J; Plachot M
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(6):629-34. PubMed ID: 1430908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program.
    Frydman R; Belaisch-Allart J; Parneix I; Forman R; Hazout A; Testart J
    Fertil Steril; 1988 Sep; 50(3):471-5. PubMed ID: 2970407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
    von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
    Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of plasma progesterone (rapid assay) during ovarian stimulation for in vitro fertilization using LHRH agonists and hMG].
    Boulieu D; Ayzac L; Nanez M; Karass M; Payan F; Guérin JF; Mathieu C; Pinatel MC
    Contracept Fertil Sex; 1993 Jan; 21(1):27-32. PubMed ID: 7951590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine profiles and luteal function during GnRH-analogue/HMG therapy.
    Braendle W; Lindner C; Lichtenberg V; Goepel E; Bettendorf G
    Hum Reprod; 1989 Nov; 4(8 Suppl):121-6. PubMed ID: 2533217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist.
    Younis JS; Matilsky M; Radin O; Ben-Ami M
    Fertil Steril; 2001 Aug; 76(2):294-9. PubMed ID: 11476775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian stimulation using human menopausal gonadotrophins with or without LHRH analogues in a long protocol for in-vitro fertilization: a prospective randomized comparison.
    Antoine JM; Salat-Baroux J; Alvarez S; Cornet D; Tibi C; Mandelbaum J; Plachot M
    Hum Reprod; 1990 Jul; 5(5):565-9. PubMed ID: 2144296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periovulatory follicular fluid hormone levels in spontaneous human cycles.
    Seibel MM; Smith D; Dlugi AM; Levesque L
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1073-7. PubMed ID: 2498380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.
    Albano C; Felberbaum RE; Smitz J; Riethmüller-Winzen H; Engel J; Diedrich K; Devroey P
    Hum Reprod; 2000 Mar; 15(3):526-31. PubMed ID: 10686191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).
    Olivennes F; Belaisch-Allart J; Emperaire JC; Dechaud H; Alvarez S; Moreau L; Nicollet B; Zorn JR; Bouchard P; Frydman R
    Fertil Steril; 2000 Feb; 73(2):314-20. PubMed ID: 10685535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the use of a pure urinary FSH stimulation regime in patients unsuccessfully treated with hMG in an in vitro fertilization program.
    Grillo M; Buck S; Freys I; Mettler L
    Gynecol Obstet Invest; 1989; 28(4):169-73. PubMed ID: 2533578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
    Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG
    Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients.
    Choi YS; Ku SY; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Hum Reprod; 2006 Aug; 21(8):2015-21. PubMed ID: 16601008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
    Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of halving the daily dose of triptorelin at the start of ovarian stimulation on hormone serum levels and the outcome of in vitro fertilization.
    Fábregues F; Peñarrubia J; Creus M; Casamitjana R; Vanrell JA; Balasch J
    Fertil Steril; 2005 Mar; 83(3):785-8. PubMed ID: 15749520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen response in polycystic ovarian syndrome to FSH treatment after LHRH agonist suppression.
    Hamori M; Zwirner M; Clédon P; Tinneberg HR
    Int J Fertil; 1992; 37(3):171-5. PubMed ID: 1355764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and influence of an endogenous serum luteinizing hormone surge after ovulation induction in stimulated cycles.
    Kainz C; Reinthaller A; Schneider B; Fischl F; Bieglmayer C
    Gynecol Endocrinol; 1994 Dec; 8(4):227-32. PubMed ID: 7709761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.